3 Passive Income Secrets for Dividend Investors
You'll make a lot more money if you know how to find and keep dividend payers in your portfolio.
Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
---|---|---|---|---|
ABT
Abbott Laboratories
|
$110.22 | $193B | -5.2% | 146.0% |
ISRG |
$206.10 | $74B | -34.1% | 101.3% |
TDOC |
$34.83 | $6B | -78.8% | 1.7% |
NVCR |
$73.30 | $8B | -60.2% | 314.1% |
UNH |
$517.40 | $485B | 28.1% | 198.5% |
You'll make a lot more money if you know how to find and keep dividend payers in your portfolio.
These reliable businesses have delivered steadily growing profits to shareholders for decades, and they could keep it going indefinitely.
These stocks have each raised their payouts to shareholders for at least half of a century.
Advances in the core business highlight stable growth prospects.
Abbott Laboratories is a blue chip worth scooping up when it goes on sale.
These two businesses are stronger than ever, but their stock prices are at their lowest points in at least a year.
They're profitable, growing, hiking their payouts, and surviving the bear market without breaking a sweat.
Declines in the market make now the time to go bargain hunting.
Abbott generated strong growth in Q1 despite a significant drop in nutritional revenue.
There are more stormy waters ahead, but they might not be a problem in the end.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.